The MIDS technology platform, used by us under a free licence from our founder shareholder, is protected by numerous patent applications now in the national phase in key geographic areas and already granted in China (grants in other territories almost certain to follow shortly). The Intellectual Property is 100% owned by our founding shareholder and licensed to MIDS Cardiac™.


NanoTesla Dx world class team is developing POC hand held devices using a next-generation nano magnetic medical diagnostic technology.
© 2023 NanoTesla Dx. All rights reserved.